WHO ICTRP trial
Can lung inflammation be reduced by temporarily removing specific white blood…
ISRCTN42695423 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN42695423 |
|---|---|
| Public title | Can lung inflammation be reduced by temporarily removing specific white blood cells from the bloodstream? |
| Scientific title | Trial of monocyte depletion in experimental lung inflammation: a single centre, double-blind, randomised, controlled trial |
| Primary sponsor | University of Edinburgh (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Experimental Lung Inflammation Injury, Occupational Diseases, Poisoning Injury of other and unspecified intrathoracic organs |
| Interventions | Study A: To characterise the relationship between blood neutrophil/monocyte accumulation and lung inflammation after inhalation of LPS. Duration of nebulised LPS intervention: 30 - 60 minutes Duration of Bronchoscopy and BAL: 30 minutes… |
| Registration date | May 8, 2009 |
| Target size | 42 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: